ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

BDTX Company Profile and Key Details

NASDAQ : BDTX

Black Diamond Therapeutics, Inc.

$2.00

0.2793+16.24%

Open: 11:48 AM

63.99

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

BDTX Stock Price Chart

Stock Price Today

Black Diamond Therapeutics, Inc. (BDTX) stock surged +16.24%, trading at $2.00 on NASDAQ, up from the previous close of $1.72. The stock opened at $1.83, fluctuating between $1.75 and $2.05 in the recent session.

Stock Snapshot

1.72

Prev. Close

1.83

Open

113.28M

Market Cap

56.66M

Number of Shares

1.75

Day Low

2.05

Day High

-1.57

P/E Ratio

76.17%

Free Float in %

-1.27

EPS (TTM)

2.26

Book Value

-1.29

Cash Flow per Share

15.16M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 19, 2025	2.36	2.78	1.71	1.72	112.79M
Mar 18, 2025	1.73	1.73	1.62	1.68	283.49K
Mar 17, 2025	1.73	1.76	1.67	1.71	252.57K
Mar 14, 2025	1.74	1.75	1.68	1.72	274.53K
Mar 13, 2025	1.80	1.80	1.65	1.65	280.42K
Mar 12, 2025	1.70	1.89	1.67	1.79	427.18K
Mar 11, 2025	1.74	1.78	1.61	1.69	508.2K
Mar 10, 2025	1.85	1.92	1.59	1.71	913.9K
Mar 07, 2025	1.84	1.95	1.83	1.88	363.03K
Mar 06, 2025	1.82	1.92	1.81	1.90	205.14K
Mar 05, 2025	1.83	1.88	1.78	1.86	360.77K
Mar 04, 2025	1.87	1.88	1.77	1.81	701.05K
Mar 03, 2025	2.01	2.02	1.88	1.91	521.5K
Feb 28, 2025	1.95	2.03	1.90	2.01	360.74K
Feb 27, 2025	2.05	2.09	1.93	1.94	479.4K
Feb 26, 2025	2.05	2.09	2.01	2.05	497.3K
Feb 25, 2025	2.17	2.17	2.03	2.03	557.35K
Feb 24, 2025	2.19	2.23	2.05	2.17	428.58K
Feb 21, 2025	2.32	2.33	2.15	2.16	388.82K
Feb 20, 2025	2.34	2.35	2.26	2.28	347.55K

Contact Details

Cambridge, MA 02142

United States

Website: https://www.blackdiamondtherapeutics.comContact: 617 252 0848

About Company

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current Black Diamond Therapeutics, Inc. (BDTX) stock price?

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) stock price is $2.00 in the last trading session. During the trading session, BDTX stock reached the peak price of $2.05 while $1.75 was the lowest point it dropped to. The percentage change in BDTX stock occurred in the recent session was 16.24% while the dollar amount for the price change in BDTX stock was $0.28.

BDTX's industry and sector of operation?

The NASDAQ listed BDTX is part of Biotechnology industry that operates in the broader Healthcare sector. Black Diamond Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BDTX?

Dr. Christopher D. Roberts Ph.D.
Advisor
Dr. Elizabeth Buck Ph.D.
Co-Founder & Chief Scientific Officer
Mr. Brent Hatzis-Schoch Esq., J.D.
Chief Operating Officer & Gen. Counsel
Ms. Melanie Morrison
Chief Devel. Officer
Mr. Tai-An Lin Ph.D.
Senior Vice President of Translational Science & Discovery Biology
Dr. Sergey Yurasov M.D., Ph.D.
Chief Medical Officer
Dr. Fang Ni Pharm.D.
Chief Financial Officer, Principal Financial Officer and Chief Bus. Officer
Ms. Elizabeth L. Montgomery
Chief People Officer
Dr. David M. Epstein Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Ms. Erika Jones
Vice President of Fin., Corporation Controller & Principal Accounting Officer

How BDTX did perform over past 52-week?

BDTX's closing price is 8.18% higher than its 52-week low of $1.59 where as its distance from 52-week high of $7.66 is -77.55%.

How many employees does BDTX have?

Number of BDTX employees currently stands at 24.

Link for BDTX official website?

Official Website of BDTX is: https://www.blackdiamondtherapeutics.com

How do I contact BDTX?

BDTX could be contacted at phone 617 252 0848 and can also be accessed through its website. BDTX operates from One Main Street, Cambridge, MA 02142, United States.

How many shares of BDTX are traded daily?

BDTX stock volume for the day was 15.16M shares. The average number of BDTX shares traded daily for last 3 months was 2.73M.

What is the market cap of BDTX currently?

The market value of BDTX currently stands at $113.28M with its latest stock price at $2.00 and 56.66M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	24
Beta	2.52
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology